Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CDK4 amplification
i
Other names:
CDK4, PSK-J3, Cyclin-dependent kinase 4
Associations
(9)
News
Trials
B | Sensitive
C2 | Sensitive
C3 | Sensitive
D | Sensitive
B | Resistant
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
EGFR
Tyrosine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
FGF
Chemotherapy
Epigenetics
Wnt Signaling Inhibitors
Cancel
Non Small Cell Lung Cancer
Liposarcoma
Mucosal Melanoma
Soft Tissue Sarcoma
Osteosarcoma
Glioblastoma
Melanoma
Diffuse Large B Cell Lymphoma
gefitinib
B
CDK4 amplification
|
Non Small Cell Lung Cancer
|
gefitinib
palbociclib
C2
CDK4 amplification
|
Liposarcoma
|
palbociclib
C3
CDK4 amplification
|
Soft Tissue Sarcoma
|
palbociclib
dalpiciclib
C2
CDK4 amplification
|
Mucosal Melanoma
|
dalpiciclib
bevacizumab
C3
CDK4 amplification
|
Glioblastoma
|
bevacizumab
palbociclib + lenvatinib
C3
CDK4 amplification
|
Osteosarcoma
|
palbociclib + lenvatinib
docetaxel + eribulin mesylate
D
CDK4 amplification
|
Liposarcoma
|
docetaxel + eribulin mesylate
toripalimab-tpzi
C3
CDK4 amplification
|
Melanoma
|
toripalimab-tpzi
R-CHOP
C3
CDK4 amplification
|
Diffuse Large B Cell Lymphoma
|
R-CHOP
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
